These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33840052)

  • 1. Pharmacotherapy for Frontotemporal Dementia.
    Khoury R; Liu Y; Sheheryar Q; Grossberg GT
    CNS Drugs; 2021 Apr; 35(4):425-438. PubMed ID: 33840052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.
    Panza F; Lozupone M; Seripa D; Daniele A; Watling M; Giannelli G; Imbimbo BP
    Nat Rev Neurol; 2020 Apr; 16(4):213-228. PubMed ID: 32203398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.
    Seelaar H; Rohrer JD; Pijnenburg YA; Fox NC; van Swieten JC
    J Neurol Neurosurg Psychiatry; 2011 May; 82(5):476-86. PubMed ID: 20971753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies.
    Gazzina S; Manes MA; Padovani A; Borroni B
    Eur J Pharmacol; 2017 Dec; 817():76-85. PubMed ID: 28579383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy and clinical trials in frontotemporal dementia: past, present, and future.
    Tsai RM; Boxer AL
    J Neurochem; 2016 Aug; 138 Suppl 1(Suppl 1):211-21. PubMed ID: 27306957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frontotemporal dementias.
    Waldö ML
    Psychiatr Clin North Am; 2015 Jun; 38(2):193-209. PubMed ID: 25998110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontotemporal dementia and primary progressive aphasia: an update.
    Kirshner HS
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):504-11. PubMed ID: 20717853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review.
    Pan XD; Chen XC
    Transl Neurodegener; 2013 Apr; 2(1):8. PubMed ID: 23597030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.
    Chitramuthu BP; Bennett HPJ; Bateman A
    Brain; 2017 Dec; 140(12):3081-3104. PubMed ID: 29053785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs.
    Logroscino G; Imbimbo BP; Lozupone M; Sardone R; Capozzo R; Battista P; Zecca C; Dibello V; Giannelli G; Bellomo A; Greco A; Daniele A; Seripa D; Panza F
    Expert Opin Pharmacother; 2019 Jun; 20(9):1091-1107. PubMed ID: 31002267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal dementia: implications for understanding Alzheimer disease.
    Goedert M; Ghetti B; Spillantini MG
    Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006254. PubMed ID: 22355793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From FUS to Fibs: what's new in frontotemporal dementia?
    Burrell JR; Hodges JR
    J Alzheimers Dis; 2010; 21(2):349-60. PubMed ID: 20413882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal dementia.
    Perry DC; Miller BL
    Semin Neurol; 2013 Sep; 33(4):336-41. PubMed ID: 24234354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.
    Huin V; Barbier M; Bottani A; Lobrinus JA; Clot F; Lamari F; Chat L; Rucheton B; Fluchère F; Auvin S; Myers P; Gelot A; Camuzat A; Caillaud C; Jornéa L; Forlani S; Saracino D; Duyckaerts C; Brice A; Durr A; Le Ber I
    Brain; 2020 Jan; 143(1):303-319. PubMed ID: 31855245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology.
    Scarioni M; Gami-Patel P; Timar Y; Seelaar H; van Swieten JC; Rozemuller AJM; Dols A; Scarpini E; Galimberti D; ; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
    Ann Neurol; 2020 Jun; 87(6):950-961. PubMed ID: 32281118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinsonism in frontotemporal dementias.
    Rowe JB
    Int Rev Neurobiol; 2019; 149():249-275. PubMed ID: 31779815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on frontotemporal dementia.
    Arvanitakis Z
    Neurologist; 2010 Jan; 16(1):16-22. PubMed ID: 20065792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.